Cargando…

Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda

BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Napyo, Agnes, Tylleskär, Thorkild, Mukunya, David, Tumuhamye, Josephine, Musaba, Milton W., Ojok Arach, Anna Agnes, Waako, Paul, Tumwine, James K., Ndeezi, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561159/
https://www.ncbi.nlm.nih.gov/pubmed/33057393
http://dx.doi.org/10.1371/journal.pone.0240529
_version_ 1783595212270993408
author Napyo, Agnes
Tylleskär, Thorkild
Mukunya, David
Tumuhamye, Josephine
Musaba, Milton W.
Ojok Arach, Anna Agnes
Waako, Paul
Tumwine, James K.
Ndeezi, Grace
author_facet Napyo, Agnes
Tylleskär, Thorkild
Mukunya, David
Tumuhamye, Josephine
Musaba, Milton W.
Ojok Arach, Anna Agnes
Waako, Paul
Tumwine, James K.
Ndeezi, Grace
author_sort Napyo, Agnes
collection PubMed
description BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old HIV exposed infants in Lira district, Northern Uganda. METHODS: This prospective cohort study was conducted from 2018–2020 at the PMTCT clinic at Lira Regional Referral Hospital and included 472 mother-infant pairs. HIV-infected pregnant women were recruited, followed up at delivery and 6 weeks postpartum. We used a structured questionnaire to obtain data on socio-demographic, reproductive-related, HIV-related characteristics and adherence. Data were analysed using Stata to estimate adjusted risk ratios using Poisson regression models to ascertain barriers and enablers of adherence to infant nevirapine prophylaxis. RESULTS: Barriers to infant adherence are maternal characteristics including: younger age (≤20 years adjusted risk ratio (ARR) = 1.55; 95% CI: 1.1–2.2), missing a viral load test during pregnancy (ARR: 1.4; 95% CI: 1.1–1.7) and not receiving nevirapine syrup for the baby after childbirth (ARR = 6.2; 95% CI: 5.1–7.6). Enablers were: having attained ≥14 years of schooling (ARR = 0.7; 95% CI: 0.5–0.9), taking a nevirapine-based regimen (ARR = 0.6; 95% CI: 0.4–0.9), long-term ART (≥ 60 months ARR = 0.75; 95% CI: 0.6–0.9), accompanied by a husband to hospital during labour and childbirth (ARR = 0.5; 95% CI: 0.4–0.7) and labour starting at night (ARR = 0.7; 95% CI: 0.6–0.8). CONCLUSION AND RECOMMENDATIONS: Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART.
format Online
Article
Text
id pubmed-7561159
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75611592020-10-21 Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda Napyo, Agnes Tylleskär, Thorkild Mukunya, David Tumuhamye, Josephine Musaba, Milton W. Ojok Arach, Anna Agnes Waako, Paul Tumwine, James K. Ndeezi, Grace PLoS One Research Article BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old HIV exposed infants in Lira district, Northern Uganda. METHODS: This prospective cohort study was conducted from 2018–2020 at the PMTCT clinic at Lira Regional Referral Hospital and included 472 mother-infant pairs. HIV-infected pregnant women were recruited, followed up at delivery and 6 weeks postpartum. We used a structured questionnaire to obtain data on socio-demographic, reproductive-related, HIV-related characteristics and adherence. Data were analysed using Stata to estimate adjusted risk ratios using Poisson regression models to ascertain barriers and enablers of adherence to infant nevirapine prophylaxis. RESULTS: Barriers to infant adherence are maternal characteristics including: younger age (≤20 years adjusted risk ratio (ARR) = 1.55; 95% CI: 1.1–2.2), missing a viral load test during pregnancy (ARR: 1.4; 95% CI: 1.1–1.7) and not receiving nevirapine syrup for the baby after childbirth (ARR = 6.2; 95% CI: 5.1–7.6). Enablers were: having attained ≥14 years of schooling (ARR = 0.7; 95% CI: 0.5–0.9), taking a nevirapine-based regimen (ARR = 0.6; 95% CI: 0.4–0.9), long-term ART (≥ 60 months ARR = 0.75; 95% CI: 0.6–0.9), accompanied by a husband to hospital during labour and childbirth (ARR = 0.5; 95% CI: 0.4–0.7) and labour starting at night (ARR = 0.7; 95% CI: 0.6–0.8). CONCLUSION AND RECOMMENDATIONS: Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART. Public Library of Science 2020-10-15 /pmc/articles/PMC7561159/ /pubmed/33057393 http://dx.doi.org/10.1371/journal.pone.0240529 Text en © 2020 Napyo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Napyo, Agnes
Tylleskär, Thorkild
Mukunya, David
Tumuhamye, Josephine
Musaba, Milton W.
Ojok Arach, Anna Agnes
Waako, Paul
Tumwine, James K.
Ndeezi, Grace
Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title_full Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title_fullStr Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title_full_unstemmed Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title_short Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
title_sort barriers and enablers of adherence to infant nevirapine prophylaxis against hiv 1 transmission among 6-week-old hiv exposed infants: a prospective cohort study in northern uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561159/
https://www.ncbi.nlm.nih.gov/pubmed/33057393
http://dx.doi.org/10.1371/journal.pone.0240529
work_keys_str_mv AT napyoagnes barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT tylleskarthorkild barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT mukunyadavid barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT tumuhamyejosephine barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT musabamiltonw barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT ojokarachannaagnes barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT waakopaul barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT tumwinejamesk barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda
AT ndeezigrace barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda